Literature DB >> 24273665

Perinatal mortality rate as a quality indicator of healthcare in Al-dakhiliyah region, oman.

Asha Santosh1, Geeta Zunjarwad, Ilham Hamdi, Jamila A Al-Nabhani, Bahaa E Sherkawy, Ibrahim H Al-Busaidi.   

Abstract

OBJECTIVES: This study aimed to provide insight into the causes of stillbirths and early neonatal deaths and identify better intervention strategies.
METHODS: This was a retrospective study during a 7-year period (January 2003 to December 2009) of all stillbirths and early neonatal deaths at the Nizwa regional referral hospital in Al-Dakhiliyah region, Oman.
RESULTS: Of a total 27,668 births, there were 244 stillbirths and 157 early neonatal deaths. The perinatal mortality rate (PMR) was 14.49/1,000 births. The period-specific rates were 17.23/1,000 in 2003, 18.33/1,000 in 2004, 15.20/1,000 in 2005, 12.20/1,000 in 2006, 12.46/1,000 in 2007 and 12.09/1000 in 2008. This decline in the death rate was significant (P = <0.005). The rate rose in 2009 to 15.63/1,000, mostly from an increase in early neonatal deaths (congenital anomalies). The most common identifiable cause of stillbirth was congenital anomalies (18.82%), in which central nervous system anomalies were most common. Other causes include abruptio placentae (13%), cord accidents (12%), and intrauterine growth restriction (IUGR), while the cause remained unknown in 22.59%. Congenital anomalies accounted for 53.50% of early neonatal deaths followed by prematurity (23.56%) and birth asphyxia (5.73%). Extremes of maternal age were related to higher PMRs.
CONCLUSION: An overall improvement in the stillbirths and neonatal death rates was witnessed; however, further improvement is warranted for common avoidable fetal and maternal risk factors. Extra care needs to be provided for women who are at risk of developing complications such as gestational diabetes, pregnancy-induced hypertension, IUGR, etc.

Entities:  

Keywords:  Health Care; Maternal Age; Oman; Perinatal Mortality; Quality Indicators; Stillbirth

Year:  2013        PMID: 24273665      PMCID: PMC3836644          DOI: 10.12816/0003314

Source DB:  PubMed          Journal:  Sultan Qaboos Univ Med J        ISSN: 2075-051X


  5 in total

1.  Classification of stillbirth by relevant condition at death (ReCoDe): population based cohort study.

Authors:  Jason Gardosi; Sue M Kady; Pat McGeown; Andre Francis; Ann Tonks
Journal:  BMJ       Date:  2005-10-19

2.  Risk factors for antepartum and intrapartum stillbirth: a population-based study.

Authors:  Darios Getahun; Cande V Ananth; Wendy L Kinzler
Journal:  Am J Obstet Gynecol       Date:  2007-06       Impact factor: 8.661

3.  Pattern of neonatal and postneonatal deaths over a decade (1995--2004) at a Military Hospital in Saudi Arabia.

Authors:  Muhammad A Majeed-Saidan; Fawaz T Kashlan; Atyah A Al-Zahrani; Faisal Y Ezzedeen; Amer N Ammari
Journal:  Saudi Med J       Date:  2008-06       Impact factor: 1.484

4.  An analytic study of the trends in perinatal and neonatal mortality rates in the State of Qatar over a 30-year period (1977 to 2007): a comparative study with regional and developed countries.

Authors:  K Salameh; S Rahman; H Al-Rifai; A Masoud; S Lutfi; G Abdouh; F Omar; S ul Islam Khan; A Bener
Journal:  J Perinatol       Date:  2009-07-30       Impact factor: 2.521

5.  Two year audit of perinatal mortality at Kathmandu Medical College Teaching Hospital.

Authors:  M Shrestha; D S Manandhar; S Dhakal; N Nepal
Journal:  Kathmandu Univ Med J (KUMJ)       Date:  2006 Apr-Jun
  5 in total
  2 in total

1.  Re: perinatal mortality rate as a quality indicator of healthcare in Al-dakhiliyah region, oman.

Authors:  Mahmood D Al-Mendalawi
Journal:  Sultan Qaboos Univ Med J       Date:  2014-04-07

2.  [Risk factors for maternal and perinatal mortality among women undergoing cesarean section in Lubumbashi, Democratic Republic of Congo II].

Authors:  Xavier Kinenkinda; Olivier Mukuku; Faustin Chenge; Prosper Kakudji; Peter Banzulu; Jean-Baptiste Kakoma; Justin Kizonde
Journal:  Pan Afr Med J       Date:  2017-04-17
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.